CS logo
small CS logo
Centro Catanese Di Oncologia; Oncologia Medica

Catania, Sicilia, Italy
Hospital in Italy
SP54 C.da CubbP54 a, 11, Contrada Cubba Marletta, 11, Misterbianco CT

About Centro Catanese Di Oncologia; Oncologia Medica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centro Catanese Di Oncologia; Oncologia Medica


During the past decade, Centro Catanese Di Oncologia; Oncologia Medica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Catanese Di Oncologia; Oncologia Medica" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Centro Catanese Di Oncologia; Oncologia Medica


According to Clinical.Site data, the most researched conditions in "Centro Catanese Di Oncologia; Oncologia Medica" are "Breast Cancer" (4 trials), "Colorectal Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Centro Catanese Di Oncologia; Oncologia Medica" in a lesser frequency.

Clinical Trials Intervention Types at Centro Catanese Di Oncologia; Oncologia Medica


Most popular intervention types in "Centro Catanese Di Oncologia; Oncologia Medica" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "trastuzumab [Herceptin]" (2 trials), "5-Fluorouracil (5-FU)" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro Catanese Di Oncologia; Oncologia Medica


The vast majority of trials in "Centro Catanese Di Oncologia; Oncologia Medica" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Centro Catanese Di Oncologia; Oncologia Medica


Currently, there are NaN active trials in "Centro Catanese Di Oncologia; Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centro Catanese Di Oncologia; Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Catanese Di Oncologia; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".